Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases.

Reviews on recent clinical trials

Volumn 1, Issue 3, 2006, Pages 193-200

  Ding, Changhai ^a   Jones, Graeme ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATLIZUMAB; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ADULT ONSET STILL DISEASE; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANIMAL; CLINICAL TRIAL; CROHN DISEASE; DISEASE MODEL; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; CROHN DISEASE; DISEASE MODELS, ANIMAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 43249100959     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488706778250168     Document Type: Review

References (30)